|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 290 DKK | -1.63% |
|
-0.41% | -25.26% |
| Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
| Apr. 12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
ChemoMetec A/S reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was DKK 427.16 million compared to DKK 281.13 million a year ago. Net income was DKK 159.47 million compared to DKK 88.35 million a year ago.
Basic earnings per share from continuing operations was DKK 9.16 compared to DKK 5.08 a year ago. Diluted earnings per share from continuing operations was DKK 9.16 compared to DKK 5.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.26% | 735M | |
| +73.49% | 12.37B | |
| -18.10% | 7.96B | |
| +15.55% | 7.09B | |
| +3.39% | 5.83B | |
| +11.77% | 5.35B | |
| +29.65% | 4.63B | |
| -17.74% | 4B | |
| -35.20% | 2.41B | |
| +2.10% | 2B |
CHEMOMETEC A/S 
